NCT07468916 2026-03-13
Ropeginterferon Alfa-2b for the Treatment of Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes and Chronic Myelomonocytic Leukemia
Jonsson Comprehensive Cancer Center
Phase 2 Not yet recruiting
Clinical Trials
9 trialsNCT07449286 2026-03-04
IFN-α in Relapse Prevention.
Peking University People's Hospital
Phase 2 Not yet recruiting
NCT07394153 2026-02-06
PACRIMYEL
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Phase 2 Not yet recruiting
NCT07269470 2025-12-16
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
M.D. Anderson Cancer Center
Phase 2 Not yet recruiting
NCT07007052 2025-11-26
TAGVEN
French Innovative Leukemia Organisation
Phase 2 Not yet recruiting
NCT06900088 2025-03-28
Selinexor Combined With Azacitidine Therapy in High-Risk Myeloid Neoplasms Patients
Institute of Hematology & Blood Diseases Hospital, China
Phase 2 Not yet recruiting
NCT06598969 2024-09-19
TMLI-MA
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 2 Not yet recruiting
NCT06602323 2024-09-19
TMLI-RI
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Phase 2 Not yet recruiting
NCT06050941 2024-03-05
Reduced Intensive Idarubicin and Cytarabine Plus Venetoclax as First-line Treatment for Adults AML and MDS
First Affiliated Hospital of Zhejiang University
Phase 2 Not yet recruiting